The global healthcare sector attracted equity investment throughout the pandemic, and it is still pouring in. The April-to-June period marked the seventh straight quarter of increased funding, which reached $34.7 billion across nearly 1,600 deals in the period.
Last year, CB Insights tallied record healthcare equity funding of $80.6 billion, spanning more than 5,500 deals. The firm attributes the industry’s lure to the potential for medical innovation to address the challenges of aging populations and the rising prevalence of chronic disease.
